![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/70 | |
A61P 11/00 | |||
A61K 31/7056 | |||
A61M 15/00 | |||
A61M 11/00 | |||
A61K 9/00 | |||
A61P 43/00 |
(11) | Number of the document | 2914269 |
(13) | Kind of document | T |
(96) | European patent application number | 13785446.9 |
Date of filing the European patent application | 2013-10-30 | |
(97) | Date of publication of the European application | 2015-09-09 |
(45) | Date of publication and mention of the grant of the patent | 2020-07-29 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2013/072691 |
Date | 2013-10-30 |
(87) | Number | WO 2014/067986 |
Date | 2014-05-08 |
(30) | Number | Date | Country code |
2794066 | 2012-10-31 | CA | |
201261720641 P | 2012-10-31 | US | |
2795753 | 2012-11-15 | CA | |
201313832672 | 2013-03-15 | US |
(72) |
NILSSON, Ulf, SE
LEFFLER, Hakon, SE
HENDERSON, Neil, GB
SETHI, Tariq, GB
MACKINNON, Alison, GB
|
(73) |
Galecto Biotech AB,
Cobis Ole Mål es Vej 3, 2200 Copenhagen,
DK
|
(54) | GALACTOSIDE INHIBITOR OF GALECTIN-3 AND ITS USE FOR TREATING PULMONARY FIBROSIS |
GALACTOSIDE INHIBITOR OF GALECTIN-3 AND ITS USE FOR TREATING PULMONARY FIBROSIS |